Etodolac is a nonsteroidal anti-inflammatory drug (NSAID) approved by the U.S. Food and Drug Administration in January 1991.
Antigen Description
Etodolac is a nonsteroidal anti-inflammatory agent with potent analgesic and antiarthritic properties. It is effective in the treatment of osteoarthritis, rheumatoid arthritis, ankylosing sponylitis, and in the alleviation of postoperative pain. Etodolac is the international non-proprietary name of 1,8-diethyl-1,3,4,9-tetrahydropyrano-indole-1-acetic acid.
Keywords
Etodolac
Citations
Publication ()
Have you cited DAG1190 in a publication? Let us know and earn a reward for your research.
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.
COA
Publication 
Loading ......
